Literature DB >> 23986343

Zoledronic acid and its accentuating effect on tumor radiosensitivity.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23986343      PMCID： PMC3755938          DOI： 10.1634/theoncologist.2013-0054

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  5 in total

1.  Combined effects of bisphosphonate and radiation on osteosarcoma cells.

Authors:  Kazuteru Ryu; Hiroaki Murata; Kazutaka Koto; Naoyuki Horie; Takaaki Matsui; Yasunori Nishigaki; Tomoya Sakabe; Hideyuki Takeshita; Megumi Itoi; Shinya Kimura; Eishi Ashihara; Taira Maekawa; Shinji Fushiki; Toshikazu Kubo
Journal:  Anticancer Res       Date:  2010-07       Impact factor: 2.480

2.  Zoledronic acid significantly enhances radiation‑induced apoptosis against human fibrosarcoma cells by inhibiting radioadaptive signaling.

Authors:  Kazutaka Koto; Hiroaki Murata; Shinya Kimura; Yasushi Sawai; Naoyuki Horie; Takaaki Matsui; Kazuteru Ryu; Eishi Ashihara; Taira Maekawa; Toshikazu Kubo; Shinji Fushiki
Journal:  Int J Oncol       Date:  2012-12-12       Impact factor: 5.650

3.  The enhancement of radiosensitivity in human esophageal squamous cell carcinoma cells by zoledronic acid and its potential mechanism.

Authors:  Yanjie You; Jianfeng Liu; Zhizhong Wang; Yuan Zhang; Yonggang Ran; Xu Guo; Huimin Liu; Haibo Wang
Journal:  Cytotechnology       Date:  2013-01-19       Impact factor: 2.058

4.  Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis.

Authors:  Antonis Valachis; Nikolaos P Polyzos; Robert E Coleman; Michael Gnant; Holger Eidtmann; Adam M Brufsky; Rebecca Aft; Amye J Tevaarwerk; Karen Swenson; Pehr Lind; Davide Mauri
Journal:  Oncologist       Date:  2013-02-12

5.  In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells.

Authors:  A Ugur Ural; Ferit Avcu; Muhammed Candir; Metin Guden; M Ali Ozcan
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466
  5 in total
  1 in total

1.  In reply.

Authors:  Antonis Valachis; Nikolaos P Polyzos
Journal:  Oncologist       Date:  2013
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.